About Redenlab

Redenlab Inc is an industry leading neuroscience focussed tech bio. We use speech and language biometrics to improve decision-making in clinical trials. Whether the trials take place in clinic, at home, or virtually, our tests are sensitive and reliable, accurately detecting subtle changes caused by disease or treatment. Our speech software and hardware solutions meet all the regulatory requirements for data security and integrity in clinical trials, including 21 CFR Part 11 and HIPAA.

Follow us to find out more about our groundbreaking projects and explore the future of speech analysis at www.redenlab.com.

website icon
Website
employees icon
Employees
industry icon
Industry
Biotechnology Research
location icon
Headquarter
585 Collins St, 669, Melbourne, Victoria 3000, AU
description icon
Founded
2017
description icon
Keywords
Science, Pharmaceuticals, Technology, Biomarkers, Acoustics, Language, Clinical Trials, Biometrics, Speech, Autism, Parkinson's Disease, Neurology, Dementia, Neuroscience, Neurodegeneration, Rare Disease, Dysphagia, Motor Neurone Disease, Huntington's Disease, Analysis Pipeline, Ataxia, Neurodevelopment

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.

Discover the source of our data

Learn more